Hints and tips:
Related Special Reports
...Carolyn Solan, head of external partnerships at consumer drugs group Haleon, which largely produces over-the-counter drugs that can be advertised more easily, said that “while partnering with expert patients...
...“There’s been a reduction of assets that don’t have the promise to be transformative medicines....
...Infections from multi-drug resistant bacteria cause an estimated 35,000 deaths in the EU every year, according to the European Medicines Agency....
...This has affected supplies of drugs like hormone replacement therapies and medicines for ADHD, partly due to spikes in demand....
...The UK Medicines and Healthcare Regulatory Agency (MHRA) has also struggled to approve drugs at the same rate as the EU, making it difficult for makers of generic medicines to enter the UK market....
...A decision from the US Food and Drug Administration on Eli Lilly’s donanemab drug was originally due by the end of the first quarter but the breakthrough medicine will now be subject to a further review...
...First, the government’s pricing scheme for branded drugs, which affects many off-patent medicines, has been highly volatile, culminating in a 26.5 per cent tax on branded medicines last year, nearly half...
...LillyDirect also uses online pharmacy TruePill to dispense its medicines....
...Jack O’Meara, chief executive of Ochre Bio, told the Financial Times: “There still remains a huge unmet need there and we hope this partnership with Boehringer will be able to develop medicines that solve...
...A decision on Eli Lilly’s donanemab drug from the US Food and Drug Administration was originally due by the end of the first quarter, but the medicine will now be subject to a further review by an advisory...
...“We learnt from that: never assume you’re going to win; keep building better and better medicine.”...
...“Up until this medicine, there was nothing available for these kids, no way to stop that relentless decline.”...
...Shares of Huadong Medicine and Hua Medicine are down a quarter in the past year, along with a broader slump in the sector as stocks normalise following a pandemic surge....
...Every fortnight, retired business owner Carolyn Davis drives more than 300 miles from her home in Florida’s Pensacola Beach to a hospital in Atlanta, Georgia, for an hour-long infusion of a novel medicine...
...The Centers for Medicare & Medicaid Services said last month that Medicare Part D drug benefit plans will cover weight loss medicines when they are approved to treat a separate medical problem, such as heart...
...“A large number” of inspectors from Germany, Europe’s largest inspectorate, are refusing to visit China for fear of arrest, according to the German Medicines Manufacturers’ Association (BAH)....
...The US Food and Drug Administration will allow Florida to import medicines from Canada, making it the first state to capitalise on rules designed to lower the cost of prescription drugs....
...“It will encourage them to make sure the medicines are available here and it’s a route for people to get tested with the new medicines in development.”...
...oral obesity medicine watched by analysts....
...For all companies facing the new Medicare regime, much rides on drug discovery. The best-placed companies can buy or build highly prized new medicines. US reforms will put Big Pharma under pressure....
...AstraZeneca has a portfolio of well-established cancer drugs including lung cancer medicine Tagrisso, which had more than $5bn in revenues last year....
...Parkinson’s patients who took the diabetes drug lixisenatide saw no worsening of their motor symptoms after a one-year trial, according to a paper published in The New England Journal of Medicine on Wednesday...
...“As we have demonstrated in Scotland, it is possible to provide access to this medicine cost-effectively within the UK,” said Haran Maheson, Daiichi Sankyo UK’s head of oncology....
...Last year Loyal, a veterinary medicine company, announced that it had met the FDA’s “reasonable expectation of effectiveness” test for a drug it is developing to lengthen canine lives....
...The Medicines and Healthcare Products regulatory agency first authorised Mounjaro, also known as tirzepatide, in November but not enough of the regular format of the drug was available to supply the UK....
International Edition